Acadia Pharmaceuticals | Créances Commerciales



Trade Debtors Changement Date
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
ALKERMES USD 321.75M 72.97M 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Corcept Therapeutics USD 61.82M 7.84M 2025-03
Cytokinetics USD 2.01M 14.64M 2025-03
Eisai JPY 220.02B 15.62B 2025-03
Eli Lilly USD 14B 727.8M 2025-03
Incyte USD 823.13M 30.02M 2025-03
J&J USD 16.02B 1.18B 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Pfizer USD 14.74B 32M 2025-03
Prothena USD 0 0 2024-12
PTC Therapeutics USD 210.5M 51.94M 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Acadia Pharmaceuticals Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.